Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.
Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy. Curr Opin Mol Ther. 1999 Aug; 1(4):471-9.
View in:
PubMed
subject areas
Adenocarcinoma
Animals
Antibodies, Viral
Antigen Presentation
Antigens, Neoplasm
Autoimmunity
Canarypox virus
Cancer Vaccines
Cell Compartmentation
Clinical Trials as Topic
Combined Modality Therapy
Cytokines
DNA, Recombinant
Fowlpox virus
Genetic Vectors
Humans
Immunotherapy
Immunotherapy, Active
Male
Mice
Mice, Transgenic
Neoplasm Metastasis
Neoplasm Transplantation
Poxviridae
Promoter Regions, Genetic
Prostatic Neoplasms
Rats
Recombinant Fusion Proteins
Salvage Therapy
Self Tolerance
Smallpox Vaccine
Species Specificity
Vaccination
Vaccinia
Viral Vaccines